Given Rises to 5-Month High as Patients Enroll in Pillcam Trial
Given Imaging Ltd. (GIVN) advanced to the highest in more than five months after the maker of a pill-sized camera to diagnose digestive ailments said about 700 patients have enrolled in a PillCam COLON 2 trial.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.